Open-Label Trial of Immunogenicity and Safety of a 13-Valent Pneumococcal Conjugate Vaccine in Adults ≥50 Years of Age in Mexico

This open-label multicenter clinical trial conducted in Mexico assessed the immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) in adults ≥50 years of age not previously vaccinated with the 23-valent pneumococcal polysaccharide vaccine (PPSV23). The PCV13 elicited a robus...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Vaccine Immunol
Huvudupphovsmän: Tinoco, Juan Carlos, Juergens, Christine, Ruiz Palacios, Guillermo M., Vazquez-Narvaez, Jorge, Enkerlin-Pauwells, Hermann Leo, Sundaraiyer, Vani, Pathirana, Sudam, Kalinina, Elena, Gruber, William C., Scott, Daniel A., Schmoele-Thoma, Beate
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2015
Ämnen:
Vaccines
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4308865/
https://ncbi.nlm.nih.gov/pubmed/25499011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00711-14
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk